Detalles de la búsqueda
1.
The high identity of the Trypanosoma cruzi Group-I of trans-sialidases points them as promising vaccine immunogens.
Proteins
; 91(10): 1444-1460, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37323089
2.
Systemic inflammatory Th1 cytokines during Trypanosoma cruzi infection disrupt the typical anatomical cell distribution and phenotypic/functional characteristics of various cell subsets within the thymus.
Microbes Infect
; : 105337, 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615883
3.
Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
Acta Trop
; 241: 106889, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893830
4.
Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.
Vaccine
; 40(15): 2311-2323, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279330
Resultados
1 -
4
de 4
1
Próxima >
>>